23andme Holding Co (ME) Growth Rates Comparisons to Major Pharmaceutical Preparations Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Suppliers, else..
 
23andme Holding Co  (ME)
 

23andme Holding Co Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ME Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q2 MRQ) -37.92 % 8.56 % 7.79 % 4.66 %
Q / Q Revenue Growth (Q2 MRQ) -46.97 % 8.87 % 6.43 % 4.04 %
Y / Y Revenue Growth (for 12 months ending Q2 TTM) -12.2 % 9.46 % 6.31 % %
Sequential Revenue Growth (for 12 months ending Q2 TTM) -7.93 % 2.49 % 1.94 % 1.17 %
Revenue 5 Year Average Growth - 8.75 % 9.34 % 13.48 %


ME's Growth Comparisons in I. Quarter 2025




23andme Holding Co's Revenue were slashed by -37.92% in the first quarter 2025 from the same quarter a year ago, to $ 25 millions, while sales in theMajor Pharmaceutical Preparations industry grew by 8.56%, and underperformed the 7.79% Revenue growth in the Healthcare sector. Although both Major Pharmaceutical Preparations industry and Healthcare sector posted higher gains than 4.66% overall market increase, 23andme Holding Co was trailing overall market in the first quarter.

Top-line fell by -46.97% from the fourth quarter results. Comparing the annual growth, sales of % on average in last five years, to the S & P 500's, including only Businesses with the first quarter 2025 financial results, average yearly sales growth is 13.48%. 23andme Holding Co grew less than the market.

ME Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
PGS
-41.11 %
-
PGS Point in Time
-61.82 %
-
PGS Over Time
21.19 %
-
Telehealth
-14.44 %
-
Telehealth Point in Time
-15.24 %
-
Telehealth Over Time
-11.94 %
-
Consumer services
-55.05 %
-
Consumer services Point in Time
-53.85 %
-
Consumer services Over Time
15.7 %
-
Research services
431.32 %
-
Research services Point in Time
-45.93 %
-
Research services Over Time
-55.94 %
-
Service
-40.64 %
-
Service Point in Time
-53.75 %
-
Service Over Time
9.53 %
-
United States
-37.25 %
-
United Kingdom
-34.56 %
-
Canada
-35.53 %
-
Other regions
-40.4 %
-
Research services Related Party
-
-
Total
-37.92 %
-87.02 %


Growth Rates of ME's Income in the first quarter 2025


ME Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q2 MRQ) - 72.25 % 56.77 % 10.34 %
Sequential Operating Income Change (Q2 MRQ) - 15.97 % 17.79 % 4.86 %
Y / Y Operating Income Growth (Q2 TTM) - 89.19 % 50.92 % 3.63 %
Sequential Operating Income Growth (Q2 TTM) - 14.31 % 10.68 % 1.1 %
Operating Income 5 Year Avg. Change - 14.98 % 10.62 % 28.66 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q2 MRQ) - 100.79 % 136.05 % 7.75 %
Sequential Income from Cont. Ops. Change (Q2 MRQ) - -2.13 % 2.39 % 7.23 %
Y / Y Income from Cont. Ops. Change (Q2 TTM) - - 45.98 % 10.69 %
Sequential Income from Cont. Ops. Change (Q2 TTM) - - 27.98 % 2.43 %
Income from Cont. Ops. 5 Year Avg. Change - 14.8 % 8.95 % -24.17 %

ME Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q2 MRQ) - 102.85 % 132.14 % 9.34 %
Q / Q Net Income Growth (Q2 MRQ) - -2.17 % 4.12 % 7.52 %
Y / Y Net Income Change (Q2 TTM) - 52.77 % 56.82 % 10.17 %
Sequential Net Income Change (Q2 TTM) - 17.68 % 20.74 % 2.82 %
Net Income 5 Year Avg. Growth - 14.99 % 9.41 % 30.75 %

ME's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q2 MRQ) - 89.55 % 136.05 % 7.75 %
Sequential EPS from Cont. Ops. Change (Q2 MRQ) - -3.39 % 2.39 % 7.23 %
Y / Y EPS from Cont. Ops. Change (Q2 TTM) - - - -
Sequential EPS from Cont. Ops. Change (Q2 TTM) - - - -37.11 %
EPS from Cont. Ops. 5 Year Avg. Growth - 2.01 % 8.95 % -24.17 %



ME EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q2 MRQ) - 91.49 % 132.14 % -24.17 %
Q / Q EPS Net Growth (Q2 MRQ) - -3.43 % 4.12 % 7.52 %
Y / Y EPS Net Change (for 12 months ending Q2 TTM) - - - -40.33 %
Sequential EPS Net Change (for 12 months ending Q2 TTM) - - - -37.11 %
EPS Net 5 Year Avg. Change - 14.99 % 9.41 % 30.75 %



23andme Holding Co reported bottom-line of $ -0.87 in the first quarter, compare to $ -2.80 in the same quarter a year ago. Major Pharmaceutical Preparations industry grew by 91.49%, while Healthcare sector increased by 132.14%, and overall market improved by 9.34%.

Bottom-line fell by -46.97% from the fourth quarter results. Comparing the annual growth, income per share of % on average in last five years, to the S & P 500's, including only Businesses with the first quarter 2025 earnings, average yearly income per share growth is 30.75%. 23andme Holding Co grew less than the market.

ME Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q2 MRQ) - 72.13 % 34.62 % -9.17 %
Sequential Free Cash Flow Change (Q2 MRQ) - 56.59 % 68.45 % 1036.6 %
Y / Y Free Cash Flow Change (Q2 TTM) - 59.23 % 46.77 % -5.43 %
Sequential Free Cash Flow Change (Q2 TTM) - 32.53 % 19.79 % -0.54 %
Free Cash Flow 5 Year Avg. Change - 3.5 % 1.82 % 18.38 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q2 MRQ) - - - -
Sequential Net Cash Flow Change (Q2 MRQ) - - - -
Y / Y Net Cash Flow Change (Q2 TTM) - - - -
Sequential Net Cash Flow Change (Q2 TTM) - - - -
Net Cash Flow 5 Year Avg. Change - 29.18 % 6.07 % 4.29 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q2 MRQ) -20.78 % 14.37 % 3.63 % 17.17 %
Sequential Capital Expenditures Change (Q2 MRQ) -27.1 % 3.24 % 4.52 % 11.05 %
Y / Y Capital Expenditures Change (Q2 TTM) -20.22 % 10.78 % 4.91 % 17.14 %
Sequential Capital Expenditures Change (Q2 TTM) -3.95 % 4.76 % 1.42 % 4.27 %
Capital Expenditures 5 Year Avg. Change - 7.3 % 7.99 % 12.12 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.